| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 16.40 | 0.08 (+0.49%) | 12.25 - 16.48 | 0.0 |
Market data as of 6:05PM 05/17/13. Quotes are delayed by at least 15 min.
The investment seeks long-term capital appreciation. The Portfolio invests primarily in equity securities, principally common stocks, of relatively large non-US companies with market capitalizations in the range of companies included in the Morgan Stanley Capital International ("MSCI®") Europe, Australasia and Far East ("EAFE®") Index. It invests at least 80% of its assets in equity securities. The Investment Manager looks for established companies in economically developed countries and may invest up to 15% of the Portfolio's assets in securities of companies whose principal business activities are located in emerging market countries.
| Total Return | 5.07% |
|---|---|
| Yield (Trailing 12 Mo.) | 2.69% |
| Expense Ratio | 1.32% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $2,500 |
| Management Tenure | 22 Years |
| Fund Inception | 01/23/1997 |
| Timeframe | LZIOX | S&P 500 | Foreign Large Blend |
|---|---|---|---|
| 1 Month | 3.53% | 1.93% | 3.94% |
| 3 Month | 3.73% | 7.18% | 3.84% |
| Year-to-Date | 7.83% | 12.74% | 7.77% |
| 1 Year | 17.67% | 16.89% | 15.45% |
| 3 Year | 9.71% | 12.80% | 6.55% |
| 5 Year | 1.63% | 5.21% | -1.30% |
| 10 Year | 8.46% | 7.88% | 8.69% |
| Since Inception | 5.07% | 10.38% | -- |
| Basic Materials | 7.86% | |
|---|---|---|
| Consumer Cyclical | 16.27% | |
| Financial Services | 19.37% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 13.31% | |
| Healthcare | 14.92% | |
| Utilities | 1.55% | |
| Communication Services | 4.29% | |
| Energy | 6.78% | |
| Industrials | 12.55% | |
| Technology | 3.09% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | 0.00 | 1.23 | 1.23 | ||
| Bond | 0.00 | 0.00 | 0.00 | ||
| Other | 0.00 | 0.98 | 0.98 | ||
| Foreign Stock | 0.00 | 93.63 | 93.63 | ||
| Foreign Bond | 0.00 | 0.00 | 0.00 | ||
| Total | 0.00 | 95.84 | 95.84 | ||
| Cash | 0.00 | 4.16 | 4.16 | ||
| Total Net Assets | $163.51M |
|---|---|
| Total Stock Holdings | 70 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Novartis AG | 17.50% | 3.78% |
| Anheuser-Busch Inbev SA | 9.81% | 3.76% |
| Unilever PLC | 7.86% | 3.21% |
| Sanofi | -- | 2.51% |
| Royal Dutch Shell PLC Class A | -0.16% | 2.38% |
| Bayer AG | -- | 2.38% |
| Sumitomo Mitsui Financial Group Inc | 39.55% | 2.22% |
| Prudential PLC | 20.97% | 2.17% |
| REXMF | -- | 2.16% |
| Informa PLC | -- | 2.14% |
| Valuation | LZIOX | Category Range |
|---|---|---|
| Price/Earnings | 12.26 | |
| Price/Book | 1.94 | |
| Price/Sales | 1.04 | |
| Price/Cash Flow | 7.96 | |
| Dividend Yield | 2.4 | |
| LT Earnings | 8.25 | |
| Historical Earnings | 18.52 | |
| Sales Growth | -1.3 | |
| Cash-Flow Growth | -6.33 | |
| Book-Value Growth | 4.61 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Below Avg | |
| Return | High |
| Pretax Return | 9.71% |
|---|---|
| Tax-adjusted Return | 8.89% |
| Tax Cost Ratio | 0.74% |
| Potential Cap Gains | -0.71% |
